About US
Contact us
-
Lilly completes acquisition of AvidEli Lilly and Company (NYSE: LLY) today announced that it has completed the acquisition of Avid Radiopharmaceuticals, Inc., a privately held company developing novel molecular imaging compounds intend2010/12/22
-
Researchers develop new malaria vaccine strategy based on ingestion of genetically modified starchThere is no efficient vaccine against malaria, although nasal and oral vaccination seems to be the most promising and suitable solution in countries where the parasite Plasmodium, which causes the dis2010/12/22
-
Novo Nordisk A/S and Emisphere Technologies, Inc. Announce License Agreement to Develop Oral Formulation of Insulin for DiabetesPRINCETON, N.J., Dec. 21, 2010 /PRNewswire/ -- Emisphere Technologies, Inc. (OTC Bulletin Board: EMIS) and Novo Nordisk A/S (NYSE: NVO) today announced that they have entered into an exclusive Develop2010/12/22
-
DNA tunneling detector embedded in a ‘Nanopore’Scientists from Imperial College London are developing technology that could ultimately sequence a person's genome in mere minutes, at a fraction of the cost of current commercial techniques. The r2010/12/21
-
FDA moves to curb Avastin's approval for breast cancerThe Food and Drug administration on Thursday revoked its approval of Roche drug Avastin for the treatment of breast cancer. The agency's action, based on findings that did not confirm that the medicin2010/12/21
-
China Nuokang Bio-Pharmaceutical Provides Update on Dipyridamole Aspirin Receives Manufacturing License for Dipyridamole AspirinChina Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales2010/12/20
-
European Medicines Agency recommends action plan to deal with possible presence of endotoxins in Baxter peritoneal dialysis solutionsThe European Medicines Agency has been informed by Baxter of the potential presence of endotoxins in their peritoneal dialysis solutions Dianeal, Extraneal and Nutrineal. These are sterile solutions u2010/12/20
-
FDA Begins Process to Remove Breast Cancer Indication from Avastin LabelDrug not shown to be safe and effective in breast cancer patients ROCKVILLE, Md., Dec. 16, 2010--The U.S. Food and Drug Administration announced today that the agency is recommending removing the b2010/12/17
-
BASF completes acquisition of CognisLudwigshafen, Germany – December 10, 2010 – BASF successfully completed its acquisition of Cognis Holding GmbH from Cognis Holding Luxembourg S.à r.l. controlled by Permira Funds, GS Capital Partners2010/12/17
-
Illegal online drug sellers prey upon 36 million Americans~Research about Dangerous Practice – and the 11 Internet Commerce Companies Partnering Together to Protect Patients – Announced as Part of White House Forum~ Illegal online drug sellers have provid2010/12/16